Want to join the conversation?
Chemicals and biofuels company $GEVO's 2Q16 revenue declined versus 2Q15, mainly due to lower production and sale of ethanol, isobutanol and distillers grains at the Luverne plant. Hydrocarbon revenue was basically flat versus same period in 2015. Company also generated grant revenue of $0.2MM in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?